"Principal établissement de soins du Tarn et Garonne, à Montauban, proposant un grand nombre de spécialités en médecine et en chirurgie. 311 lits et places en hospitalisations conventionnelles et en secteur ambulatoire. Elle dispose notamment d’un service d’urgences (7/24), de lits « lourds » (réanimation, soins continus, soins intensifs, soins palliatifs) et d’un plateau technique de pointe (bloc opératoire, chimiothérapie, IRM, scanner, accélérateur de particules, gamma caméra, etc…)."

During the past decade, Clinique du Pont de Chaume conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinique du Pont de Chaume" #1 sponsor was "UNICANCER" with 4 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Biotronik AG" with 1 trials sponsored, "Biotronik France" with 1 trials sponsored and "CeloNova BioSciences, Inc." with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique du Pont de Chaume" #1 collaborator was "AlpinARC" with 1 trials as a collaborator, "Biotronik France" with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator, "Federation Francophone de Cancerologie Digestive" with 1 trials as a collaborator and "Groupe Francais De Pneumo-Cancerologie" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Clinique du Pont de Chaume" are "Breast Cancer" (3 trials), "Atrial Fibrillation" (2 trials), "Prostate Cancer" (2 trials), "ACS - Acute Coronary Syndrome" (1 trials) and "Adenocarcinoma of Lung Metastatic to Brain" (1 trials). Many other conditions were trialed in "Clinique du Pont de Chaume" in a lesser frequency.

Most popular intervention types in "Clinique du Pont de Chaume" are "Drug" (9 trials), "Procedure" (4 trials), "Radiation" (4 trials), "Device" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "adjuvant therapy" (3 trials), "fluorouracil" (2 trials), "3-dimensional conformal radiation therapy" (1 trials), "Accelerated partial breast irradiation" (1 trials) and "Aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinique du Pont de Chaume" are 15 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Clinique du Pont de Chaume". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Clinique du Pont de Chaume, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Clinique du Pont de Chaume, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".